NCT00396617

Brief Summary

The benefits of this new material, as demonstrated in animal studies and preliminary studies in man, could provide the answer to problems encountered by surgeons in the field of phonatory implants. This novel application is a step towards resolving the very real problems which still exist in the field today. The functional concept, which will allow better control over integrating implants in tissue, should also, it is hoped, favour cellular colonization, thereby fulfilling a currently unmet medical need. The aim is to avoid well-identified potential complications linked to the use of silicone-only implants (with or without a surface coating), like leakage around the prosthesis (by cellular colonization), and so reduce the risk of protrusion/extrusion of the prosthesis as far as possible, and to avoid trauma to the peri-prosthetic tissues by repeated interventions

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
14

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Dec 2007

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 7, 2006

Completed
1.1 years until next milestone

Study Start

First participant enrolled

December 1, 2007

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

July 2, 2012

Status Verified

June 1, 2012

Enrollment Period

5.8 years

First QC Date

November 6, 2006

Last Update Submit

June 28, 2012

Conditions

Keywords

Laryngeal or pharyngo-laryngeal's carcinoma,voice prosthesis tracheooesophageal shunt,titanium beads,cellular colonizationLaryngeal or pharyngo-laryngeal's carcinoma

Outcome Measures

Primary Outcomes (1)

  • Clinical measures concerning peri and intra prosthetic leakage

    days 8,15,21,30 - months : 2 ,4,6,8, 10, 12, 15,18,21,24,30, 36

Secondary Outcomes (1)

  • Phonology's measures

    months 1, 3,12

Interventions

The device may be used for patient using another type of voice prosthesis, of for patient undergoing total laryngectomy. This device is definitively placed in two parts:The first one is introduced in the puncture (TEP) through the esophagus (retrograde way). The second part is then clipped on the first one through the tracheotomy orifice (anterograde way).A third part containing the valve can then be clipped in the prosthesis and easily removed in order to change it as often as necessary.

The second part is then clipped on the first one through the tracheotomy orifice (anterograde way).A third part containing the valve can then be clipped in the prosthesis and easily removed in order to change it as often as necessary.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age more than 18
  • total laryngectomy or pharyngo-larynctomy

You may not qualify if:

  • pregnant women-age less than 18
  • major pulmonary bronchitis
  • major neurological disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service d'ORL et de Chirurgie Cervico-Faciale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg

Strasbourg, 67082, France

RECRUITING

MeSH Terms

Conditions

Pharyngeal NeoplasmsLaryngeal NeoplasmsCarcinomaLaryngeal Diseases

Condition Hierarchy (Ancestors)

Otorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic DiseasesRespiratory Tract DiseasesRespiratory Tract NeoplasmsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Officials

  • Christian DEBRY, MD

    Hôpitaux Universitaires de Strasbourg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2006

First Posted

November 7, 2006

Study Start

December 1, 2007

Primary Completion

September 1, 2013

Study Completion

March 1, 2014

Last Updated

July 2, 2012

Record last verified: 2012-06

Locations